Snapshot from Jun 26, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / CAMP4 Therapeutics
Entity

CAMP4 Therapeutics

Tracked across 1 events · 6 articles · First seen Jun 02, 2026 · Last active Jun 04, 2026

Sentiment
0
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
4 0
Business
Fulcrum Therapeutics stock plunges on FDA concerns
Fulcrum Therapeutics, a publicly traded company, experienced a 50% stock plunge on June 1, 2026, after disclosing United States — Food and Drug Administration safety concerns related to the PRC2 inhibitor drug class, specifically regarding…
Impact: Fulcrum Therapeutics has a licensing agreement with CAMP4 Therapeutics involving potential milestone payments and royalties, which remains in place despite the discontinuation of pociredir.
Jun 02, 2026 · 6 articles
NEWSDESK
Track CAMP4 Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.